The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Vitamin D in inflammatory diseases
Open accessAbstract
Changes in vitamin D serum levels have been associated with inflammatory diseases, such as inflammatory bowel disease (IBD), rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis (MS), atherosclerosis, or asthma. Genome- and transcriptome-wide studies indicate that vitamin D signaling modulates many inflammatory responses on several levels. This includes (i) the regulation of the expression of genes which generate pro-inflammatory mediators, such as cyclooxygenases or 5-lipoxygenase, (ii) the interference with transcription factors, such as NF-κB, which regulate the expression of inflammatory genes and (iii) the activation of signaling cascades, such as MAP kinases which mediate inflammatory responses. Vitamin D targets various tissues and cell types, a number of which belong to the immune system, such as monocytes/macrophages, dendritic cells (DCs) as well as B- and T cells, leading to individual responses of each cell type. One hallmark of these specific vitamin D effects is the cell-type specific regulation of genes involved in the regulation of inflammatory processes and the interplay between vitamin D signaling and other signaling cascades involved in inflammation. An important task in the near future will be the elucidation of the regulatory mechanisms that are involved in the regulation of inflammatory responses by vitamin D on the molecular level by the use of techniques such as chromatin immunoprecipitation (ChIP), ChIP-seq, and FAIRE-seq.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–228 of 228
Miodovnik, M., Koren, R., Ziv, E., & Ravid, A. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22951 · Cited by 34
Circulating Vitamin D Metabolites and Subclinical Atherosclerosis in Type 1 Diabetes
Sachs, M. C., Brunzell, J. D., Cleary, P. A., Hoofnagle, A. N., Lachin, J. M., Molitch, M. E., Steffes, M. W., Zinman, B., & de Boer, I. H. (2013) · Diabetes Care · doi:10.2337/dc12-2020 · Cited by 34
Jamshidi, F., Zhang, J., Harrison, J. S., Wang, X., & Studzinski, G. P. (2008) · Cell Cycle · doi:10.4161/cc.7.7.5620 · Cited by 33
Association analysis of vitamin D receptor gene polymorphisms in chinese population with asthma.
Fang, W.-L., Gao, L., Liang, W., Xue, H., Bai, P., Lv, M., Wang, Y., Zhou, B., & Zhang, L. (2009) · PubMed · Cited by 33
Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on inflammatory responses in psoriasis.
Inoue, M., Matsui, T., Nishibu, A., Nihei, Y., Iwatsuki, K., & Kaneko, F. (1999) · PubMed · Cited by 33
Role of vitamin D levels and vitamin D receptor polymorphisms in relation to coronary artery disease
Shanker, J., Maitra, A., Arvind, P., Nair, J., Dash, D., Manchiganti, R., Rao, V. S., Radhika, K. N., Hebbagodi, S., & Kakkar, V. V. (2011) · Coronary Artery Disease · doi:10.1097/mca.0b013e3283472a57 · Cited by 32
Barthel, R., & Goldfeld, A. E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3612 · Cited by 31
Analysis of the 5-lipoxygenase promoter and characterization of a vitamin D receptor binding site
Sorg, B. L., Klan, N., Seuter, S., Dishart, D., Rådmark, O., Habenicht, A. J. R., Carlberg, C., Werz, O., & Steinhilber, D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.04.005 · Cited by 31
Self-citationStan, D. L., Călin, M., Mânduțeanu, I., Tucureanu, M. M., Gan, A., Butoi, E. D., Simion, V., & Simionescu, M. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1092-3 · Cited by 31
Bhalla, A. K., Paavonen, T., Williams, M. M., Delves, P., & Lydyard, P. M. (1991) · PubMed · Cited by 31
1α,25-Dihydroxyvitamin D3 promotes CD200 expression by human peripheral and airway-resident T cells
Dimeloe, S., Richards, D. F., Urry, Z., Gupta, A. K., Stratigou, V., Farooque, S. P., Saglani, S., Bush, A., & Hawrylowicz, C. M. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200651 · Cited by 30
Vitamin D deficiency, CD4+CD28null cells and accelerated atherosclerosis in chronic kidney disease
Yadav, A. K., Banerjee, D., Lal, A., & Jha, V. (2012) · Nephrology · doi:10.1111/j.1440-1797.2012.01611.x · Cited by 27
Yoon, J., & Jun, H. (1999) · Archives of Pharmacal Research · doi:10.1007/bf02979150 · Cited by 27
Upregulation of interleukin-1β production by 1,25-Dihydroxyvitamin D3 in activated human macrophages
Lee, B.-N.-R., Kim, T.-H., Jun, J., Yoo, D., Woo, J.-H., Choi, S. J., Lee, Y. H., Song, G. G., Kim, Y., Lee, J. Y., et al. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0348-z · Cited by 27
Sun, J., Zhong, W., Gu, Y., Groome, L. J., & Wang, Y. (2013) · Placenta · doi:10.1016/j.placenta.2013.12.002 · Cited by 27
Murine osteoblast interleukin 4 receptor expression: Upregulation by 1,25 dihydroxyvitamin D3
Lacey, D. L., Erdmann, J. M., Tan, H., & Ohara, J. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240530205 · Cited by 27
Schnatz, P. F., Nudy, M. S., O’Sullivan, D. M., Jiang, X., Cline, J. M., Kaplan, J. R., Clarkson, T. B., & Appt, S. E. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.03.014 · Cited by 26
Xiao, H., Shi, W., Liu, S., Zhang, B., Xu, L., Liang, X., & Liang, Y. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05133.x · Cited by 24
Vitamin D–induced up–regulation of tumour necrosis factor alpha (TNF–α) in prostate cancer cells
Golovko, O., Nazarova, N., & Tuohimaa, P. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.10.072 · Cited by 21
Jordan, S. C., Toyoda, M., Prehn, J., Lemire, J. M., Sakai, R. S., & Adams, J. S. (1989) · Molecular Immunology · doi:10.1016/0161-5890(89)90116-8 · Cited by 21
Cheraghi, N., Dai, H. D., & Raghuveer, G. (2012) · Medical Science Monitor · doi:10.12659/msm.883593 · Cited by 20
Hidaka, M., Wakabayashi, I., Takeda, Y., & Fukuzawa, K. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.014 · Cited by 18
Schnatz, P. F., Nudy, M. S., O’Sullivan, D. M., Jiang, X., Cline, J. M., Kaplan, J. R., Clarkson, T. B., & Appt, S. E. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31824cfa8f · Cited by 17
CD69 Is a TGF-β/1α,25-dihydroxyvitamin D3 Target Gene in Monocytes
Wöbke, T. K., von Knethen, A., Steinhilber, D., & Sorg, B. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064635 · Cited by 16
Self-citationTransforming Growth Factor beta (TGFβ)
Serra, R. A. (2002) · Wiley eBooks · doi:10.1038/npg.els.0000934 · Cited by 14
Petrovic, N., Knight, D. A., Bomalaski, J. S., Thompson, P. J., & Misso, N. L. A. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.08.006 · Cited by 13
Towards the Management of Inflammation: Recent Developments of mPGES-1 Inhibitors
Dallaporta, M., Pecchi, É., Thirion, S., Jean, A., & Troadec, J. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488910789753549 · Cited by 11
Regulation of fucosyltransferase-VII expression in peripheral lymph node high endothelial venules
(1998) · doi:10.1002/(sici)1521-4141(199810)28:10
Cited by
Latic, N., & Erben, R. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186483 · Cited by 283
Oral vitamin D rapidly attenuates inflammation from sunburn: an interventional study
Scott, J. F., Das, L. M., Ahsanuddin, S., Qiu, Y., Binko, A. M., Traylor, Z. P., Debanne, S. M., Cooper, K. D., Boxer, R., & Lu, K. Q. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.04.040 · Cited by 95
Vitamin D as a therapeutic option for sunburn: clinical and biologic implications
Scott, J. F., & Lu, K. Q. (2017) · DNA and Cell Biology · doi:10.1089/dna.2017.3978 · Cited by 13
Metadata
- Authors
- Wöbke, T. K., Sorg, B. L., & Steinhilber, D.
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2014-07-02
- Volume
- 5
- Pages
- 244-244
- ISSN
- 1664-042X (ISSN-L)
- OpenAlex
- W2036977715
- Cited by
- 284
- References
- 228
- FWCI
- 17.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.